National Institute on Aging; Notice of Closed Meeting, 42315-42316 [E9-20156]
Download as PDF
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20163 Filed 8–20–09; 8:45 am]
National Cancer Institute; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
srobinson on DSKHWCL6B1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
I—Career Development.
Date: October 5–6, 2009.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Robert Bird, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8113, Bethesda, MD 20892–8328. 301–496–
7978. birdr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20161 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NIHSupported Centers for Population Health and
Health Disparities.
Date: September 21–23, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott North, 5701
Marinelli Road, Rockville, MD 20852.
Contact Person: Lalita D. Palekar, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7141, Bethesda,
MD 20892, 301–496–7575,
palekarl@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
and Applied Emerging Technologies in
Biospecimen Science.
Date: November 4–5, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Viatcheslav A.
Soldatenkov, MD, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, 6116 Excecutive Blvd Room
8057, Bethesda, MD 20892–8329, 301–451–
4758, soldatenkovv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
42315
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20160 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
October 14, 2009, 8 a.m. to October 15,
2009, 6 p.m., Hilton Washington DC/
Rockville Executive Meeting C, 1750
Rockville Pike, Rockville, MD, 20852
which was published in the Federal
Register on July 17, 2009, 74FR34765.
The name of the committee on this
Federal Register Notice has been
amended to read ‘Epidemiology,
Prevention, Control & Population
Sciences’ and not as otherwise stated.
The meeting is closed to the public.
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20158 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel Sleep and
Age.
Date: September 18, 2009.
Time: 12:30 p.m. to 4:30 p.m.
E:\FR\FM\21AUN1.SGM
21AUN1
42316
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20814
(Telephone Conference Call).
Contact Person: Jeannette L. Johnson,
Ph.D., Scientific Review Officer, National
Institutes on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7705,
JOHNSONJ9@NIA.NIH.GOV.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20156 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Organization, Functions, and
Delegations of Authority
srobinson on DSKHWCL6B1PROD with NOTICES
Part G, Indian Health Service, Proposed
Functional Statement
Office of Direct Service and Contracting
Tribes (ODSCT) (GABI)
(1) Provides Agency leadership and
advocacy for Direct Service Tribes (DST)
in the development of health policy,
program management, budget
formulation and resource allocation and
advises the IHS Director and senior
management on DST issues and
concerns; (2) provides Agency
leadership concerning policy
development and Agency functions and
responsibilities associated with selfdetermination contracting (Title I of the
Indian Self-Determination and
Education Assistance Act, Public Law
93–638, as amended), monitors Agency
compliance with self-determination
policies, administrative procedures and
guidelines, and advises the Director,
IHS, and senior management on
activities and issues related to selfdetermination contracting; (3) provides
Agency leadership in the development
of contract support cost (CSC) policy,
and fulfills national operational
responsibilities, with respect to the CSC
program administered by IHS; (4)
provides Agency leadership with
respect to policy development and
issues concerning new Federally
recognized/restored Tribes; (5)
administers a national statutorily
mandated grant program designed to
assist Tribes and Tribal organizations in
beginning and/or expanding self-
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
determination activities; (6) serves as
the principal liaison with DST Tribal
leaders, the Direct Service Tribes
Advisory Committee (DSTAC), national
Indian or Tribal organizations, interTribal consortiums, Area health boards,
and Service Unit health boards; (7)
coordinates quarterly DSTAC and
annual DST meetings to provide a forum
for DST Tribal leaders to express their
concerns and primary issues relating to
direct health care delivery by the IHS;
(8) coordinates and facilitates meetings
between Direct Service and Title I
contracting Tribal delegations and the
Office of the Director at Headquarters,
during national meetings and at other
locations as required; (9) maintains a
central database of contact information
for Tribal leaders, health directors,
health programs, etc.; (10) assures that
Indian Tribes and Tribal organizations
are informed regarding pertinent health
policy and program management issues
and that consultation, with participation
by Indian Tribes and Tribal
organizations, occurs during the
development of IHS policies and
Agency decision making; (11) provides
technical assistance and support to IHS
Area Offices and to Tribes in
administering health programs; and (12)
participates in cross-cutting issues and
processes including but not limited to
emergency preparedness/security,
budget formulation, self-determination
issues, Tribal shares computations, and
resolution of audit findings as needed.
This reorganization shall be effective
on August 14, 2009.
Dated: August 13, 2009.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. E9–20056 Filed 8–20–09; 8:45 am]
BILLING CODE 4165–16–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0352]
Prescription Drug User Fee Act IV
Information Technology Assessment
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: In the last decade, the Food
and Drug Adminstration (FDA) has
achieved great success in reforming and
modernizing its regulatory processes
and responsibilities as a result of
changes and improvements driven by
the requirements of the Prescription
Drug User Fee Act (PDUFA), the 1997
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
FDA Modernization Act (FDAMA), and
other legislation. PDUFA was
reauthorized by the Food and Drug
Administration Amendments Act of
2007, Title I, Prescription Drug User Fee
Amendments of 2007 (PDUFA IV). FDA
plans to make even greater progress
during the PDUFA IV timeframe (Fiscal
Years 2008 through 2012), building on
the foundation established in previous
years. The additional resources
provided by user fees, when combined
with appropriations, have enabled the
FDA to modernize its information
technology infrastructure and begin a
monumental transformation from a
paper-based to an electronic work
environment.
As part of the PDUFA IV
commitment, FDA published the
PDUFA IV Information Technology (IT)
Plan for comment to allow the public to
provide feedback as FDA moves towards
a fully electronic standards-based
submission and review environment.
FDA reviewed the comments, updated
the plan, and published the updated
version in June 2008 (73 FR 36880; June
30, 2008).
Under the PDUFA IV IT Plan an
assessment of progress against the plan
is conducted on an annual basis. The
most recent report, which is available at
https://www.fda.gov/oc/pdufa/, reflects
the current assessment of the PDUFA IV
IT Plan. The report contains four
columns. The first three columns were
previously published as part of the
original plan. The last column, labeled
‘‘Current Status’’ provides details of the
activities for each project assessed. The
next assessment will be published in
November 2009.
More information on the PDUFA
program is available at https://
www.fda.gov/oc/pdufa/.
DATES: Submit written or electronic
comments on the assessment at any
time. These comments will be
considered as the agency makes annual
updates to the plan each fiscal year.
ADDRESSES: Submit written requests for
single copies of the IT Assessment to the
Office of the Chief Information Officer
(HFA–080), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857. Send one selfaddressed adhesive label to assist that
office in processing your requests.
Submit written comments on the IT
Assessment to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the assessment.
E:\FR\FM\21AUN1.SGM
21AUN1
Agencies
[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Pages 42315-42316]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20156]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel Sleep and Age.
Date: September 18, 2009.
Time: 12:30 p.m. to 4:30 p.m.
[[Page 42316]]
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20814 (Telephone
Conference Call).
Contact Person: Jeannette L. Johnson, Ph.D., Scientific Review
Officer, National Institutes on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-
402-7705, JOHNSONJ9@NIA.NIH.GOV.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-20156 Filed 8-20-09; 8:45 am]
BILLING CODE 4140-01-P